home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

35 rows where docket_id = "NRC-2022-0218" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: posted_date, posted_month, last_modified, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 4

  • 2024 19
  • 2023 10
  • 2025 5
  • 2022 1

document_type 2

  • Supporting & Related Material 31
  • Proposed Rule 4

agency_id 1

  • NRC 35
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
NRC-2022-0218-0195 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 LTR-24-0219 Dana Smetherman, Chief Executive Officer, American College of Radiology, Letter re: SECY-24-0067 on Proposed Rule - Reporting Nuclear Medicine Injection Extravasation as Medical Events Supporting & Related Material   2025-02-11T00:00:00Z 2025 2     2025-05-21T06:20:58Z   0 0 090000648694f2b4
NRC-2022-0218-0196 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 10-16-24 Letter from Simon Davies to NRC Supporting & Related Material   2025-02-11T00:00:00Z 2025 2     2025-05-21T06:20:57Z   0 0 090000648694f2b5
NRC-2022-0218-0199 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 10-21-24 DG-8062 Public Comment From YSC Supporting & Related Material   2025-02-11T00:00:00Z 2025 2     2025-05-21T06:20:58Z   0 0 090000648694f2b8
NRC-2022-0218-0197 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 LTR-24-0227 Simon Davies, Executive Director, Teen Cancer America, Patients for Safer Nuclear Medicine Spokesperson, comments on Nuclear Regulatory Commission's Draft Regulatory Guide DG-8062 for radiopharmaceutical extravasation reporting Supporting & Related Material   2025-02-11T00:00:00Z 2025 2     2025-05-21T06:20:58Z   0 0 090000648694f2b6
NRC-2022-0218-0198 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 Venus Gines Commenting on Draft Regulatory Guide Supporting & Related Material   2025-02-11T00:00:00Z 2025 2     2025-05-21T06:20:58Z   0 0 090000648694f2b7
NRC-2022-0218-0190 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 07-10-24 Ron Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: Information Correction Request submitted to NRC in February 2023, and the most recent NRC OIG findings Supporting & Related Material   2024-09-30T00:00:00Z 2024 9     2025-05-21T06:22:01Z   0 0 09000064867a2e8b
NRC-2022-0218-0191 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 08-27-24 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: NRC's reply and the proposed rule regarding the reporting of extravasations Supporting & Related Material   2024-09-30T00:00:00Z 2024 9     2025-05-21T06:22:01Z   0 0 09000064867a2e8d
NRC-2022-0218-0189 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 April 11, 2023 - NRC Response to Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter regarding Extravasation, Abnormal Occurrence reporting, and Information Correction Requests Supporting & Related Material   2024-09-25T00:00:00Z 2024 9     2025-05-21T06:22:02Z   0 0 0900006486786688
NRC-2022-0218-0188 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 June 28, 2023 - Response to Ronald Lattanze Appeal Letter to the NRC Information Quality Coordinator dated May 12, 2023 re: SECY-22-0043, “Petition for Rulemaking and Rulemaking Plan on Reporting Nuclear Medicine Injection Extravasations as Medical Events" Supporting & Related Material   2024-09-25T00:00:00Z 2024 9     2025-05-21T06:22:02Z   0 0 09000064867846bb
NRC-2022-0218-0187 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 August 8, 2024 - NRC Response to R. Lattanze July 2024 Letter Supporting & Related Material   2024-09-25T00:00:00Z 2024 9     2025-05-21T06:22:02Z   0 0 09000064867846b9
NRC-2022-0218-0185 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 August 7, 2024 - Letter to NRC medical staff re proposed rule and 99mTC case report Supporting & Related Material   2024-08-25T00:00:00Z 2024 8     2025-05-21T06:24:12Z   0 0 090000648667632d
NRC-2022-0218-0184 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 April 4, 2023 - LTR-23-0081 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: Information Correction Request Follow-up Supporting & Related Material   2024-08-25T00:00:00Z 2024 8     2025-05-21T06:24:12Z   0 0 0900006486672f5e
NRC-2022-0218-0186 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 July 1, 2024 Email to Raymond Furstenau from Teen Cancer America and K. Williams Response Regarding Extravasations rulemaking Supporting & Related Material   2024-08-25T00:00:00Z 2024 8     2025-05-21T06:24:12Z   0 0 090000648667632e
NRC-2022-0218-0182 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 June 15, 2023 - LTR-23-0157 - Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, Letter re: Extravasations, Abnormal Occurrence reporting, and Information Correction Request Supporting & Related Material   2024-08-23T00:00:00Z 2024 8     2025-05-21T06:24:12Z   0 0 0900006486672ea7
NRC-2022-0218-0183 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 February 15, 2024 - LTR-24-0030 Mary Ajango, Spokesperson, Patients for Safer Nuclear Medicine Coalition, Letter re: concerns about reporting requirements for extravasations ML24051A042 Supporting & Related Material   2024-08-23T00:00:00Z 2024 8     2025-05-21T06:24:12Z   0 0 0900006486674c6a
NRC-2022-0218-0173 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 Draft for ACMUI Review - Draft Model Procedures for Evaluating and Reporting Extravasation Medical Events Supporting & Related Material   2024-08-22T00:00:00Z 2024 8     2025-05-21T06:24:13Z   0 0 090000648665e6b5
NRC-2022-0218-0176 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 June 11, 2024 - Draft Report - Subcommittee on Extravasations Supporting & Related Material   2024-08-22T00:00:00Z 2024 8     2025-05-21T06:24:13Z   0 0 090000648665e6f3
NRC-2022-0218-0180 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 February 16, 2023 - LTR-23-0038 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: Extravasation, Abnormal Occurrence Reporting, and Information Correction Requests Supporting & Related Material   2024-08-22T00:00:00Z 2024 8     2025-05-21T06:24:13Z   0 1 090000648665e7ce
NRC-2022-0218-0174 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 June 17, 2024 - MUI Extravasations Meeting Handout Supporting & Related Material   2024-08-22T00:00:00Z 2024 8     2025-05-21T06:24:13Z   0 0 090000648665e6b8
NRC-2022-0218-0175 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 August 21, 2024 - For ACMUI Review - Preliminary Extravasation Proposed Rule Package Supporting & Related Material   2024-08-22T00:00:00Z 2024 8     2025-05-21T06:24:13Z   0 0 090000648665e6bb
NRC-2022-0218-0178 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 June 17, 2024 - Transcript of Meeting of the Advisory Committee on the Medical Uses of Isotopes - Pages 1 - 93 Supporting & Related Material   2024-08-22T00:00:00Z 2024 8     2025-05-21T06:24:13Z   0 0 090000648665ec26
NRC-2022-0218-0181 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 May 12, 2023 LTR-23-0129 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: Abnormal Occurrence Reporting, and Information Correction Request Supporting & Related Material   2024-08-22T00:00:00Z 2024 8     2025-05-21T06:24:13Z   0 0 09000064866601ee
NRC-2022-0218-0179 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 NRC Response to Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC - Letter regarding Extravasation. Abnormal Occurrence Reporting and Information Correction Requests Supporting & Related Material   2024-08-22T00:00:00Z 2024 8     2025-05-21T06:24:13Z   0 0 090000648665ed18
NRC-2022-0218-0177 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 June 17, 2024 - Final Report - Advisory Committee on Medical Uses of Isotopes (ACMUI) Supporting & Related Material   2024-08-22T00:00:00Z 2024 8     2025-05-21T06:24:13Z   0 0 090000648665e6f2
NRC-2022-0218-0053 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 STC-23-053 Notification of Proposed Rulemaking Fusion Energy Systems Supporting & Related Material   2023-07-24T00:00:00Z 2023 7     2025-05-21T06:33:38Z   0 1 0900006485d2a16f
NRC-2022-0218-0045 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 Reporting Nuclear Medicine Injection Extravasations as Medical Events Proposed Rule   2023-07-18T00:00:00Z 2023 7     2025-05-21T06:33:43Z 2023-15130 0 0 0900006485cd23b6
NRC-2022-0218-0043 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 STC-23-033 Comment Extension Request from OAS Board Supporting & Related Material   2023-07-13T00:00:00Z 2023 7     2025-05-21T06:33:51Z   0 0 0900006485ca04ae
NRC-2022-0218-0033 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 May 24 Extravasation Public Meeting Summary Supporting & Related Material   2023-06-29T00:00:00Z 2023 6     2025-05-21T06:34:10Z   0 0 0900006485c1b265
NRC-2022-0218-0032 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 May 24 Extravasation Public Meeting Transcript Supporting & Related Material   2023-06-29T00:00:00Z 2023 6     2025-05-21T06:34:10Z   0 0 0900006485c1b261
NRC-2022-0218-0009 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 Reporting Nuclear Medicine Injection Extravasations as Medical Events; Correction Proposed Rule   2023-04-25T00:00:00Z 2023 4 2023-04-25T00:00:00Z   2025-05-21T06:35:07Z 2023-08685 0 0 09000064859844f2
NRC-2022-0218-0005 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 Preliminary Proposed Rule Language Supporting & Related Material   2023-04-20T00:00:00Z 2023 4     2025-05-21T06:35:17Z   0 0 090000648596a26d
NRC-2022-0218-0004 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 Reporting Nuclear Medicine Injection Extravasations as Medical Events Proposed Rule   2023-04-19T00:00:00Z 2023 4 2023-04-19T00:00:00Z 2023-09-02T03:59:59Z 2025-05-21T06:35:17Z 2023-08238 0 0 090000648595e557
NRC-2022-0218-0003 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 Mary Ajango, Spokesperson, Young Survival Coalition, Patients for Safer Nuclear Medicine Coalition Spokesperson, Letter re: NRC’s decision about extravasations Supporting & Related Material   2023-03-21T00:00:00Z 2023 3     2025-05-21T06:35:43Z   0 1 0900006485815e65
NRC-2022-0218-0002 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 March 11, 2024 - 12. LTR-23-0081 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: Information Correction Request Follow-up Supporting & Related Material   2023-03-21T00:00:00Z 2023 3     2025-05-21T06:35:43Z   0 1 0900006485815e66
NRC-2022-0218-0001 NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 Reporting Nuclear Medicine Injection Extravasations as Medical Events Proposed Rule   2022-12-30T00:00:00Z 2022 12     2025-05-21T06:36:17Z 2022-28356 0 0 0900006485568e61

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 292.376ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API